Experimental type 1 diabetes drug shelters pancreas cells from immune system attack
Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals’ lifespan. The drug is unique, according to the researchers, because it targets insulin-making beta cells in the pancreas directly … Read more
